Qualitätssicherungs-Initiative Pathologie QuIP GmbH (quip)
Industry / private company
Location:
Berlin,
Germany (DE)
Proficiency testing of PIK3CA mutations in HR+/HER2-breast cancer on liquid biopsy and tissue (2022)
Vollbrecht C, Hoffmann I, Lehmann A, Merkelbach-Bruse S, Fassunke J, Wagener-Ryczek S, Ball M, et al.
Journal article
Reproducibility of mRNA-Based Testing of ESR1, PGR, ERBB2, and MKI67 Expression in Invasive Breast Cancer-A Europe-Wide External Quality Assessment (2021)
Erber R, Hartmann A, Fasching P, Rübner M, Stöhr R, Beckmann M, Zentgraf M, et al.
Journal article
Erratum zu Mitteilungen der Deutschen Gesellschaft für Pathologie (Der Pathologe, (2021), 42, 3, (352-353), 10.1007/s00292-021-00931-y) (2021)
Joehrens K, Baretton G, Schildhaus HU, Agaimy A, Scheel A, Schwammborn K, Laenger F, et al.
Journal article, Erratum
Europe-side external quality assessment (EQA) of RNA based testing of ER, PR, HER2 and Ki67 in invasive breast cancer (2020)
Erber R, Hartmann A, Fasching P, Stöhr R, Beckmann M, Zentgraf M, Rübner M, et al.
Conference contribution
Harmonization and Standardization of Panel-Based Tumor Mutational Burden Measurement: Real-World Results and Recommendations of the Quality in Pathology Study (2020)
Stenzinger A, Endris V, Budczies J, Merkelbach-Bruse S, Kazdal D, Dietmaier W, Pfarr N, et al.
Journal article